These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2279584)

  • 1. Active suppression of the proliferative response to interleukin-2 in tumour-bearing mice.
    Zajícová A; Holán V
    Folia Biol (Praha); 1990; 36(6):301-11. PubMed ID: 2279584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of indomethacin, cytokines, and cyclosporin A on tumor growth and the subsequent development of cancer cachexia.
    Gelin J; Andersson C; Lundholm K
    Cancer Res; 1991 Feb; 51(3):880-5. PubMed ID: 1988128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-bearing animals synthesize a decreased level of mRNA for the inducible 55,000 MW interleukin-2 receptor.
    Holán V; Lipoldová M
    Immunology; 1990 Apr; 69(4):626-8. PubMed ID: 2335381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors.
    Civin CI; Dorfman N; Eggers A; Fink K; Penvose D; Hsu CK; Wunderlich JR
    J Immunol; 1979 Dec; 123(6):2550-7. PubMed ID: 159318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
    Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
    J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.
    Mellow L; Sabbadini E
    Immunology; 1985 Oct; 56(2):235-43. PubMed ID: 2932383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression in viral oncogenesis. III. Effects of virus infection on interleukin 1 and interleukin 2 generation and responsiveness.
    Strayer DS; Horowitz M; Leibowitz JL
    J Immunol; 1986 Dec; 137(11):3632-8. PubMed ID: 3023485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
    Sakurai T; Yamada M; Simamura S; Motoyoshi K
    Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 production by immunologically hyporeactive tumour-bearing mice.
    Holán V; Lipoldová M
    Br J Cancer; 1990 May; 61(5):667-70. PubMed ID: 2337505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of IL-2-dependent proliferation by a prostaglandin-dependent suppressor factor.
    Ferreri NR; Herzog WR; Askenase PW
    J Immunol; 1993 Mar; 150(6):2102-11. PubMed ID: 8450204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of cyclophosphamide-induced MAC-1+ natural suppressor cells on IL-2 and IL-4 utilization in MLR.
    Brooks JC; Hoskin DW
    Transplantation; 1994 Nov; 58(10):1096-103. PubMed ID: 7974716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
    Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
    J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour metastasis in mice with reduced immune reactivity. IV. Restoration of relative resistance to metastasis formation in thymectomized sub-lethally irradiated mice by spleen cells.
    Suurküla M; Boeryd B
    Pathol Eur; 1975; 10(4):299-305. PubMed ID: 1208121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice.
    McIntosh JK; Jablons DM; Mulé JJ; Nordan RP; Rudikoff S; Lotze MT; Rosenberg SA
    J Immunol; 1989 Jul; 143(1):162-7. PubMed ID: 2499626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I; Miller SC
    Nat Immun; 1993; 12(2):66-78. PubMed ID: 8318817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of production and sorption of interleukin 2 by lymphoid cells during growth of transplanted sarcoma].
    Kushko LIa; Semenova-Kobzar' RA; Iudin VM; Koval'chuk EV; Berezhnaia NM
    Eksp Onkol; 1988; 10(1):34-7. PubMed ID: 3259499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the immunological disturbance in murine schistosomiasis japonica from the viewpoint of the interleukin cascade reaction.
    Yamashita T; Watanabe T; Sendo F
    Immunology; 1987 Oct; 62(2):215-21. PubMed ID: 3119470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low responsiveness of spleen cells from tumour-bearing mice to recombinant interleukin-1 and interleukin-2. Impaired expression of interleukin-2 receptors.
    Holán V; Lipoldová M
    Int J Cancer; 1990 Apr; 45(4):798-800. PubMed ID: 2323854
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells.
    Shu S; Chou T; Rosenberg SA
    J Immunol; 1986 May; 136(10):3891-8. PubMed ID: 3486223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.